Catalysis Science & Technology
Communication
We thank the A*STAR Institute of Chemical and Engineer-
ing Sciences (ICES), the A*STAR Singapore Bio-imaging Con-
sortium (SBIC) and the Canada Research Chairs program for
generous financial support and the University of Ottawa, Can-
ada Foundation for Innovation, and Ontario Ministry of Eco-
nomic Development and Innovation for essential infrastruc-
ture. We appreciate the assistance of Dr. Sharon Curtis for
the analyses using high-resolution mass spectroscopy.
10 M. Koura, Y. Yamaguchi, S. Kurobuchi, H. Sumida, Y.
Watanabe, T. Enomoto, T. Matsuda, A. Okuda, T. Koshizawa,
Y. Matsumoto and K. Shibuya, Bioorg. Med. Chem., 2016, 24,
3436–3446.
11 W. R. Baker, M. Stasiak, S. Swaminathan and M. Kim,
Monophosphates as mutual prodrugs of muscarinic receptor
antagonists and β-agonists for the treatment of COPD and
chronic bronchitis, WO2008/76269, June 26, 2008.
12 E. Alacid and C. Nájera, J. Org. Chem., 2009, 74, 2321–2327.
13 F. Kerins and D. F. O'Shea, J. Org. Chem., 2002, 67,
4968–4971.
Conflicts of interest
There are no conflicts to declare.
14 K. Araki, T. Katagiri and M. Inoue, J. Fluorine Chem.,
2014, 157, 41–47.
15 R. A. Hartz, V. T. Ahuja, J. E. Macor, J. J. Bronson, B.
Dasgupta, C. D. Dzierba, S. J. Nara and M. S. Karatholuvhu,
Quinazoline-based kinase inhibitors, WO2016/53794, April 7,
2016.
16 A. Lampa, H. Alogheli, A. E. Ehrenberg, E. Åkerblom, R.
Svensson, P. Artursson, U. H. Danielson, A. Karlén and A.
Sandström, Bioorg. Med. Chem., 2014, 22, 6595–6615.
17 G. T. Wang, R. A. Mantei, M. Kawai, J. S. Tedrow, D. M.
Barnes, J. Wang, Q. Zhang, P. Lou, L. A. Garcia, J. Bouska,
M. Yates, C. Park, R. A. Judge, R. Lesniewski, G. S.
Sheppard and R. L. Bell, Bioorg. Med. Chem. Lett., 2007, 17,
2817–2822.
18 Z. Cai and M. Harmata, Org. Lett., 2010, 12, 5668–5670.
19 I. P. Beletskaya and A. V. Cheprakov, Chem. Rev., 2000, 100,
3009–3066.
20 R. F. Heck, Org. React., 1982, 27, 345–390.
21 R. F. Heck and J. P. Nolley, J. Org. Chem., 1972, 37,
2320–2322.
Notes and references
1 D. King, J. E. Macor, R. E. Olson, C. I. Iwuagwu and G. N.
Karageorge, Selective NR2B antagonists, US 2013/0079338
A1, Mar. 28, 2013.
2 H. Jung, S. H. Hwang, Y. K. Kim, J. O. Lim, S. Han, S. Y.
Kim, J. Y. Yun and J. Lee, Heterocyclic compound and
organic light-emitting diode including the same, US 2013/
0112948 A1, May 9, 2013.
3 S. H. Han, S. H. Hwang, Y. K. Kim, H. J. Jung, J. O. Lim,
S. Y. Kim, E. J. Jeong, J. H. Park, E. Y. Lee, K. H. Kim and
J. W. Kim, Heterocyclic compound and organic light-
emitting diode including the same, US 2015/0048343 A1,
Feb. 19, 2015.
4 D. He, W. Jian, X. Liu, H. Shen and S. Song, J. Agric. Food
Chem., 2015, 63, 1370–1377.
5 G. R. Pettit, M. R. Rhodes, D. L. Herald, E. Hamel, J. M.
Schmidt and R. K. Pettit, J. Med. Chem., 2005, 48, 4087–4099.
6 M. J. Acerson, K. M. Fabick, Y. Wong, C. Blake, E. D. Lephart
and M. B. Andrus, Bioorg. Med. Chem. Lett., 2013, 23,
2941–2944.
7 F. Mao, J. Yan, J. Li, X. Jia, H. Miao, Y. Sun, L. Huang and X.
Li, Org. Biomol. Chem., 2014, 12, 5936–5944.
8 A. Kraft, A. C. Grimsdale and A. B. Holmes, Angew. Chem.,
Int. Ed., 1998, 37, 402–428.
22 L. Joucla, G. Cusati, C. Pinel and L. Djakovitch, Adv. Synth.
Catal., 2010, 352, 1993–2001.
23 D. W. Tay, H. Jong, Y. H. Lim, W. Wu, X. Chew, E. G. Robins
and C. W. Johannes, J. Org. Chem., 2015, 80, 4054–4063.
24 Y. Yang, J. F. Y. Lim, X. Chew, E. G. Robins, C. W. Johannes,
Y. H. Lim and H. Jong, Catal. Sci. Technol., 2015, 5,
3501–3506.
9 P. Hrobárik, V. Hrobáriková, V. Semak, P. Kasák, E.
Rakovský, I. Polyzos, M. Fakis and P. Persephonis, Org. Lett.,
2014, 16, 6358–6361.
25 H. Jong, S. T. C. Eey, Y. H. Lim, S. Pandey, N. A. B. Iqbal,
F. F. Yong, E. G. Robins and C. W. Johannes, Adv. Synth.
Catal., 2017, 359, 616–622.
This journal is © The Royal Society of Chemistry 2017
Catal. Sci. Technol.